Letter to the Editor: Remission of Graves' Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis

Thyroid, Ahead of Print.

Source: Thyroid - December 13, 2022 Category: Endocrinology Authors: Rosa Casany-Fernandez Francisco Gascon-Gimenez Enrique Juan Matarredona Solaz Felipe Pardo Lozano Jose Andres Dominguez-Moran Jordi Ferri Ciscar Jose Tomas Real Collado Source Type: research